Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)

The Menagerie of Human Lipocalins: A Natural Protein Scaffold for Molecular Recognition of Physiological Compounds

(2015) André Schiefner et al.   ACCOUNTS OF CHEMICAL RESEARCH

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies

(2014) F Huber et al.   BRITISH JOURNAL OF CANCER

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

(2014) Ali Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation

(2014) Claudia T Mendler et al.   mAbs

PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen

(2013) Ronnie C. Mease et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Anticalins: Exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins

(2013) A. Richter et al.   FEBS LETTERS

First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer

(2013) J. A. Barrett et al.   JOURNAL OF NUCLEAR MEDICINE

First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors

(2013) Klaus Mross et al.   PLoS One

Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors

(2012) D. V. Ferraris et al.   CURRENT MEDICINAL CHEMISTRY

GCPII Imaging and Cancer

(2012) C. A. Foss et al.   CURRENT MEDICINAL CHEMISTRY

Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

(2012) C. Barinka et al.   CURRENT MEDICINAL CHEMISTRY

Combinatorial Design of an Anticalin Directed against the Extra-Domain B for the Specific Targeting of Oncofetal Fibronectin

(2012) Michaela Gebauer et al.   JOURNAL OF MOLECULAR BIOLOGY

Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

(2012) S. Y. Cho et al.   JOURNAL OF NUCLEAR MEDICINE

PSMA-targeted SPECT agents: Mode of binding effect on in vitro performance

(2012) Jessie R. Nedrow-Byers et al.   PROSTATE

Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature

(2011) Mary K Samplaski et al.   MODERN PATHOLOGY

Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: Expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II

(2011) J. Tykvart et al.   PROTEIN EXPRESSION AND PURIFICATION

Ten-Year Outcomes: The Clinical Utility of Single Photon Emission Computed Tomography/Computed Tomography Capromab Pendetide (Prostascint) in a Cohort Diagnosed With Localized Prostate Cancer

(2010) Rodney J. Ellis et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

High-throughput Sorting of an Anticalin Library via EspP-mediated Functional Display on the Escherichia coli Cell Surface

(2010) Uli Binder et al.   JOURNAL OF MOLECULAR BIOLOGY

Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers

(2009) Michael C. Haffner et al.   HUMAN PATHOLOGY

High-Affinity Recognition of Lanthanide(III) Chelate Complexes by a Reprogrammed Human Lipocalin 2

(2009) Hyun Jin Kim et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Online optimization of surface plasmon resonance‐based biosensor experiments for improved throughput and confidence

(2008) Gregory De Crescenzo et al.   JOURNAL OF MOLECULAR RECOGNITION

PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma

(2008) Wenle Wang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS